Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results

Core Viewpoint - Zealand Pharma A/S will host a conference call on February 19, 2026, to present its full year 2025 financial results [1] Group 1: Conference Call Details - The call will feature President and CEO Adam Steensberg, CFO Henriette Wennicke, and CMO David Kendall, followed by a Q&A session [2] - A live audio webcast and accompanying slide presentation will be available online [3] - Participants are encouraged to register approximately 10 minutes before the call, and a recording will be accessible on the company's website afterward [4] Group 2: Company Overview - Zealand Pharma A/S is focused on developing medicines for obesity and metabolic health, leveraging over 25 years of peptide R&D expertise and advanced data-driven approaches [5] - The company has over ten drug candidates in clinical development, with two products already on the market and three in late-stage development [6] - Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in Boston, Massachusetts [6]